Bristol Myers Squibb to Discontinue Metastatic Colorectal Cancer Trial 0 16.12.2023 01:22 The Wall Street Journal The biopharmaceutical company said it will end its study that evaluated treating metastatic colorectal cancer through a combination of nivolumab and relatlimab. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
